ERBB2 and breast cancer: Fourthly, similar data obtained from SKBR-3 cells provide additional evidence to support the idea that changes in tumor microenvironments can activate intracellular growth signaling pathways and reduce sensitivity of HER2-positive breast cancer cells that are otherwise very sensitive to T-DM1 in 2D cell culture dishes.